Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Genedrive Human Genotyping Test Gets EU Certification
LONDON (Alliance News) - Molecular diagnostics firm Genedrive PLC on Thursday said its IL28B SNP human genotyping test has been given CE-IVD certification by European regulators.
The test, Genedrive said, is performed in 50 minutes from a buccal cheek swab using Genedrive's hand-held PCR instrument.
The certification validates the Genedrive platform for use in pharmacogenomics, the company said.
"We are now looking to partner with pharma and contract research organisations to support the development of SNP assays for clinical trials and clinical applications," said Genedrive Chief Executive David Budd.
Shares in Genedrive were down 12% to 55.00 pence on Thursday.
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Genedrive Shares in this article
Latest News
- Airbus CEO criticises Europe's regulatory costs as it opens new line
8 mins ago - Trump says Hormuz to 'completely open' Friday after US-Iran peace deal
11 mins ago - GLOBAL MARKETS-Stocks jump, oil slides following US-Iran peace deal
42 mins ago - Europe's STOXX 600 ends at record high as US-Iran deal lifts sentiment
46 mins ago - Amateur saboteurs: the young men carrying out attacks for gangs, Russia and Iran
1 hour ago - US-Iran pact 'very important step for peace,' France's Macron says
1 hour ago - Rolls-Royce wins "multibillion" SMR deal from Sweden's Videberg Kraft
1 hour ago
Related News
Genedrive collects £0.76m R&D tax credit
(Sharecast News) - Genedrive said on Friday that it had received a research and development tax credit refund of about £0.76m from HMRC.
Genedrive chair to step down; adds shareholder David Nugent to board
(Alliance News) - Genedrive PLC on Tuesday said it has appointed a major shareholder to its board, as it reported that Chair Ian Gilham plans to step ...
Sussex NHS trust moves to routine use of Genedrive test
(Sharecast News) - Genedrive said on Tuesday that the University Hospitals Sussex NHS Foundation Trust had moved its MT-RNR1 test into routine clinica...
Follow the stocks
